Oxbow Advisors’s Aehr Test Systems AEHR Stock Holding History

Oxbow Advisors’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,000	Closed	-$197K	–	211
2022 Q3	$197K	Hold	14,000	–	–	0.03%	224
2022 Q2	$105K	Hold	14,000	–	–	0.01%	246
2022 Q1	$142K	Hold	14,000	–	–	0.01%	255
2021 Q4	$339K	Buy	+14,000	New	+$274K	0.03%	227

Other funds holding AEHR

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Oxbow Advisors's AEHR Position: Q4 2022 in Review

Oxbow Advisors sold out of Aehr Test Systems (AEHR) in Q4 2022, closing a stake of 14,000 shares — an estimated $197K sold.

Oxbow Advisors first reported a position in AEHR in Q4 2021 and held it in 4 quarters. The position peaked at $339K in Q4 2021. 129 funds tracked by Wall St. Rank hold AEHR as of Q4 2022.

Oxbow Advisors reported no remaining Aehr Test Systems position as of Q4 2022 after selling out during the quarter.
Oxbow Advisors sold 14,000 Aehr Test Systems shares in Q4 2022, an estimated $197K.
Oxbow Advisors first reported a position in Aehr Test Systems in Q4 2021 and held it in 4 quarters.
Oxbow Advisors's Aehr Test Systems position peaked at $339K in Q4 2021.
129 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2022.

Based on Oxbow Advisors's 13F filing for Q4 2022, filed 1 Feb 2023.